CRBU · Forms 3, 4, 5
Insider trades at Caribou Biosciences, Inc.
No open-market insider buys or sells at Caribou Biosciences, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Caribou Biosciences, Inc. (CRBU) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Caribou Biosciences, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Timothy P Kelly | Chief Technology Officer | Sell | 6,228 | $1.93 | $12K | Form 4 | |
| Timothy P Kelly | Chief Technology Officer | Sell | 3,147 | $1.96 | $6K | Form 4 | |
| Barbara G Mcclung | Chief Legal Officer | Sell (10b5-1 plan) | 6,938 | $1.96 | $14K | Form 4 | |
| Ruhi Ahmad Khan | Chief Business Officer | Sell (10b5-1 plan) | 6,938 | $1.96 | $14K | Form 4 | |
| Tina M. Albertson | Chief Medical Officer | Sell (10b5-1 plan) | 1,066 | $1.96 | $2K | Form 4 | |
| Timothy P Kelly | Chief Technology Officer | Award | 45,000 | Form 4 | |||
| Barbara G Mcclung | Chief Legal Officer | Award | 45,000 | Form 4 | |||
| Ruhi Ahmad Khan | Chief Business Officer | Award | 45,000 | Form 4 | |||
| Tina M. Albertson | Chief Medical Officer | Award | 55,000 | Form 4 | |||
| Ran Zheng | Director | Options or other derivatives | Form 4 | ||||
| Nancy Whiting | Director | Options or other derivatives | Form 4 | ||||
| Natalie Sacks | Director | Options or other derivatives | Form 4 | ||||
| Dara Richardson-Heron | Director | Options or other derivatives | Form 4 | ||||
| David Lee Johnson | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.